BackStatistics
Total Visits
| Views | |
|---|---|
| Risk ...(legacy) | 375 |
| Risk ... | 82 |
Total Visits Per Month
| August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | |
|---|---|---|---|---|---|---|---|
| Risk ... | 1 | 4 | 1 | 0 | 0 | 1 | 0 |
File Visits
| Views | |
|---|---|
| RMP and Pharmacovigilance. Biosimilars. Calvo & Zuñiga.pdf(legacy) | 654 |
| RMP and Pharmacovigilance. Biosimilars. Calvo & Zuñiga.pdf | 102 |
Top country views
| Views | |
|---|---|
| United States | 234 |
| China | 38 |
| Germany | 31 |
| Spain | 26 |
| France | 26 |
| Sweden | 19 |
| Russia | 15 |
| Ukraine | 14 |
| Hong Kong SAR China | 6 |
| Ireland | 6 |
Top cities views
| Views | |
|---|---|
| Ashburn | 41 |
| Mountain View | 40 |
| Stockholm | 17 |
| Fairfield | 16 |
| Redmond | 16 |
| Sunnyvale | 15 |
| Louisville | 14 |
| Beijing | 13 |
| Ann Arbor | 12 |
| Jacksonville | 11 |